Related Experiment Video
Updated: Mar 3, 2026

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
Published on: January 23, 2026
Postoperative Pulmonary Function and Structural Remodelling After Lobectomy in Patients With and Without Chronic
Sanae Kuroda1, Tappei Shomoto1, Yuki Nishioka1
1Division of Chest Surgery, Hyogo Cancer Center, Akashi 673-8558, Japan.
Objectives:
Quantitative assessment of lung structure provides insights beyond conventional postoperative function prediction. This study examined how preoperative chronic obstructive pulmonary disease (COPD) status and emphysema distribution influence postoperative pulmonary function and structural remodelling using 3-dimensional computed tomography (3D-CT) cluster analysis.
Methods:
We retrospectively analysed 426 lobectomy cases performed between 2018 and 2023. Patients were stratified into the COPD and non-COPD groups. Predicted postoperative FEV1.0 was estimated using 3D-CT volumetry, and the measured-to-predicted FEV1.0 ratio (MPFR) was calculated. Structural parameters, including D-value (reflecting alveolar complexity) and low-attenuation area (LAA), were measured pre- and postoperatively using 3D-CT. MPFR, % change in D-value (%D-value), and LAA (%LAA) were compared between the groups using Mann-Whitney U tests. Subgroup analysis was performed based on whether the resected lobe had a higher or lower D-value than the whole lung.
Results:
Patients with COPD exhibited a significantly higher MPFR than those without COPD (117.9% vs 110.7%, P < .001). %D-value did not differ significantly between the groups (99.7% vs 98.1%, P = .476), whereas %LAA was significantly higher in non-COPD patients (134.9% vs 117.6%, P = .005). In subgroup analyses according to the presence of emphysematous resected lobes, MPFR and %D-value did not differ between the groups, and no significant difference in %LAA was observed.
Conclusions:
Patients with COPD maintain better-than-predicted postoperative function without additional structural loss, whereas non-COPD patients show volume-driven increases in LAA. Integrating functional and structural 3D-CT indexes-MPFR, D-value, and LAA-enables a comprehensive evaluation of postoperative lung remodelling, potentially improving risk stratification and surgical planning.
Clinical Registration Number:
G-441; approved on May 12, 2025.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumothorax-II
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction

